XML 34 R5.htm IDEA: XBRL DOCUMENT v3.23.4
Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Subscription Receivable
Accumulated Deficit
Total
Balance, beginning of period at Dec. 31, 2020 $ 464 $ 65,949 $ (12,763) $ (3,461,882) $ (3,408,232)
Balance, beginning of period (in shares) at Dec. 31, 2020 4,636,216        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in initial public offering, net of offering costs $ 719 25,399,954     25,400,673
Issuances of common stock, net (in shares) 7,187,500        
Conversion of convertible promissory notes, including embedded derivative, to common stock upon completion of initial public offering $ 107 4,991,324     4,991,431
Conversion of convertible promissory notes, including embedded derivative, to common stock upon completion of initial public offering (in shares) 1,068,135        
Exercise of warrants $ 1 64,751     64,752
Exercise of warrants (in shares) 12,723        
Proceeds from subscription receivable     (13,125)   (13,125)
Interest on subscription receivable   362 $ (362)   $ 362
Exercise of stock options (in shares)         259,000
Share based compensation expense   185,996     $ 185,996
Net loss       (6,843,399) (6,843,399)
Balance, end of period at Dec. 31, 2021 $ 1,291 30,708,336   (10,305,281) 20,404,346
Balance, end of period at Dec. 31, 2021 $ 65 30,709,562   (10,305,281) 20,404,346
Balance, end of period (in shares) at Dec. 31, 2021 645,229        
Balance, end of period (in shares) at Dec. 31, 2021 12,904,574        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   5,989     5,989
Exercise of stock options (in shares) 3,633        
Share based compensation expense   60,573     60,573
Net loss       (3,470,070) (3,470,070)
Balance, end of period at Mar. 31, 2022 $ 65 30,776,124   (13,775,351) 17,000,838
Balance, end of period (in shares) at Mar. 31, 2022 648,862        
Balance, beginning of period at Dec. 31, 2021 $ 65 30,709,562   (10,305,281) 20,404,346
Balance, beginning of period at Dec. 31, 2021 $ 1,291 30,708,336   (10,305,281) 20,404,346
Balance, beginning of period (in shares) at Dec. 31, 2021 645,229        
Balance, beginning of period (in shares) at Dec. 31, 2021 12,904,574        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (12,430,912)
Balance, end of period at Sep. 30, 2022 $ 65 30,980,325   (22,736,193) 8,244,197
Balance, end of period (in shares) at Sep. 30, 2022 648,862        
Balance, beginning of period at Dec. 31, 2021 $ 65 30,709,562   (10,305,281) 20,404,346
Balance, beginning of period at Dec. 31, 2021 $ 1,291 30,708,336   (10,305,281) 20,404,346
Balance, beginning of period (in shares) at Dec. 31, 2021 645,229        
Balance, beginning of period (in shares) at Dec. 31, 2021 12,904,574        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options $ 7 5,982     $ 5,989
Exercise of stock options (in shares) 72,660       3,633
Share based compensation expense   395,329     $ 395,329
Net loss       (17,564,968) (17,564,968)
Balance, end of period at Dec. 31, 2022 $ 1,298 31,109,647   (27,870,249) 3,240,696
Balance, end of period at Dec. 31, 2022 $ 65 31,110,880   (27,870,249) 3,240,696
Balance, end of period (in shares) at Dec. 31, 2022 648,862        
Balance, end of period (in shares) at Dec. 31, 2022 12,977,234        
Balance, beginning of period at Mar. 31, 2022 $ 65 30,776,124   (13,775,351) 17,000,838
Balance, beginning of period (in shares) at Mar. 31, 2022 648,862        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation expense   98,599     98,599
Net loss       (4,671,232) (4,671,232)
Balance, end of period at Jun. 30, 2022 $ 65 30,874,723   (18,446,583) 12,428,205
Balance, end of period (in shares) at Jun. 30, 2022 648,862        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation expense   105,602     105,602
Net loss       (4,289,610) (4,289,610)
Balance, end of period at Sep. 30, 2022 $ 65 30,980,325   (22,736,193) 8,244,197
Balance, end of period (in shares) at Sep. 30, 2022 648,862        
Balance, beginning of period at Dec. 31, 2022 $ 65 31,110,880   (27,870,249) 3,240,696
Balance, beginning of period (in shares) at Dec. 31, 2022 648,862        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options $ 14 1,180,672     1,180,686
Exercise of stock options (in shares) 142,315        
Share based compensation expense   158,760     158,760
Net loss       (4,816,934) (4,816,934)
Balance, end of period at Mar. 31, 2023 $ 79 32,450,312   (32,687,183) (236,792)
Balance, end of period (in shares) at Mar. 31, 2023 791,177        
Balance, beginning of period at Dec. 31, 2022 $ 65 31,110,880   (27,870,249) 3,240,696
Balance, beginning of period at Dec. 31, 2022 $ 1,298 31,109,647   (27,870,249) 3,240,696
Balance, beginning of period (in shares) at Dec. 31, 2022 648,862        
Balance, beginning of period (in shares) at Dec. 31, 2022 12,977,234        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (14,458,548)
Balance, end of period at Sep. 30, 2023 $ 1,069 46,767,623   (42,328,798) 4,439,894
Balance, end of period (in shares) at Sep. 30, 2023 10,687,724        
Balance, beginning of period at Mar. 31, 2023 $ 79 32,450,312   (32,687,183) (236,792)
Balance, beginning of period (in shares) at Mar. 31, 2023 791,177        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in initial public offering, net of offering costs $ 116 6,495,308     6,495,424
Issuances of common stock, net (in shares) 1,159,497        
Share based compensation expense   175,484     175,484
Net loss       (4,341,653) (4,341,653)
Balance, end of period at Jun. 30, 2023 $ 195 39,121,104   (37,028,836) 2,092,463
Balance, end of period (in shares) at Jun. 30, 2023 1,950,674        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in initial public offering, net of offering costs $ 874 7,254,188     7,255,062
Issuances of common stock, net (in shares) 8,737,050        
Share based compensation expense   392,331     392,331
Net loss       (5,299,962) (5,299,962)
Balance, end of period at Sep. 30, 2023 $ 1,069 $ 46,767,623   $ (42,328,798) $ 4,439,894
Balance, end of period (in shares) at Sep. 30, 2023 10,687,724